Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Accueil  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Martin A. Vogelbaum
Age : 55
Public asset : 270,504 USD
Linked companies : Cara Therapeutics, Inc.
Summary 
Mr. Martin A. Vogelbaum is Lead Independent Director at CARA Therapeutics, Inc., Independent Director at Inotek Pharmaceuticals Corp., Partner at Rho Ventures and Non-Managing Member at RMV VI LLC.

He is on the Board of Directors at CARA Therapeutics, Inc., Inotek Pharmaceuticals Corp., Nora Therapeutics, Inc. and SARcode Bioscience, Inc.

Mr. Vogelbaum was previously employed as General Partner by Oxford Bioscience Partners and General Partner by Apple Tree Partners.

He also served on the board at NephroGenex, Inc., Middlebrook Pharmaceuticals, Inc., Nuvelo, Inc., Gloucester Pharmaceuticals, Inc. and Mersana Therapeutics, Inc.

He received his AB in biology and history degree from Columbia University.


Current positions of Martin A. Vogelbaum 
NameTitle Since
Cara Therapeutics, Inc.
(Biotechnology & Medical Research)
Lead Independent Director 2015
Nora Therapeutics, Inc. Director -
Inning One Ventures LP Director -
RMV VI LLC Non-Managing Member -
Rho Ventures Partner 2005


Holdings of Martin A. Vogelbaum 
NameEquities%Valuation
Cara Therapeutics, Inc. (CARA)
(Biotechnology & Medical Research)
20,4000.044%270,504 USD


Martin A. Vogelbaum: Personal Network 
Most Read News 
11/17WARREN BUFFETT : Buffett's Berkshire bets on Big Pharma, invests in four drugmakers
RE
11/14WARREN BUFFETT : Warren Buffett's Berkshire Is Becoming Its Own Elephant Investment
DJ
11/12JACK MA : China's President Xi Jinping Pulled Plug on Jack Ma's Ant IPO
DJ
11/13ELON MUSK : Musk questions coronavirus tests, saying they gave opposite results on same day
RE
11/15ELON MUSK : Elon Musk says 'most likely' has a moderate case of COVID-19
RE
11/19MARY BARRA : GM's Barra accelerates 'all out pursuit of global EV leadership'
RE
11/13THIERRY BRETON : Google CEO apologises for document, EU's Breton warns internet is not Wild West
RE
11/17THEODOR WEIMER : Deutsche Boerse to buy 80% of ISS for $1.8 billion
RE
11/17WILLIAM ACKMAN : As Ackman hunts blockbuster deal, he counts on big backers
RE
11/19PETER THIEL : Peter Thiel joins board of antibody therapy developer AbCellera
RE
More news


© 2020 People and Ownership :   
Martin A. Vogelbaum : Connections 



Popular Business Leaders 
Jean-paul Agon Bernard Arnault Mary Barra Werner Baumann Jeff Bezos Leon Black Martin Bouygues Richard Branson Markus Braun Warren Buffett Francesco Gaetano Caltagirone Bertrand Camus Jean-pierre Clamadieu Tim Cook Jean-charles Decaux Elmar Degenhart Leonardo Del Vecchio Herbert Diess Jack Dorsey Patrick Drahi Nicandro Durante Sergio Ermotti Antoine Frérot Bill Gates Luigi Gubitosi David Henry Carl Icahn Jens Bodo Koch Arnaud Lagardère Jack Ma Catherine Macgregor Elon Musk Xavier Niel Michael O'leary Bernd Osterloh James Packer Patrick Pouyanné Pedro Pullen Parente Alexandre Ricard Masayoshi Son Carsten Spohr Friede Springer Peter Thiel Gilberto Tomazoni Philippe Varin François Villeroy De Galhau Axel Weber Dieter Zetsche Mark Zuckerberg Luca De Meo
A-Z Business Leaders